$0.969900
~0-0.01%
At Close: -
$0.930000
-0.04-4.11%
After Hours: 6:21 PM EDT
15 minutes delayed
Comments
Loading...
Estrella Immunopharma (ESLA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEstrella Immunopharma (NASDAQ:ESLA) Stock Quotes, Forecast and News Summary
Estrella Immunopharma Stock (NASDAQ: ESLA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Estrella Immunopharma (ESLA) stock?
You can purchase shares of Estrella Immunopharma (NASDAQ:ESLA) through any online brokerage.
Who are Estrella Immunopharma (ESLA) competitors?
Other companies in Estrella Immunopharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX), CARISMA Therapeutics (NASDAQ:CARM) and T2 Biosystems (NASDAQ:TTOO).
What is the forecast, or price target, for Estrella Immunopharma (ESLA) stock?
There is no analysis for Estrella Immunopharma to provide a consensus price target.
What is the current price for Estrella Immunopharma (ESLA)?
The stock price for Estrella Immunopharma (NASDAQ: ESLA) is $0.93 last updated September 26, 2024 at 6:21 PM EDT.
Does Estrella Immunopharma (ESLA) pay a dividend?
There are no upcoming dividends for Estrella Immunopharma.
When is Estrella Immunopharma (NASDAQ:ESLA) reporting earnings?
Estrella Immunopharma’s Q1 earnings are confirmed for Friday, November 1, 2024.
Is Estrella Immunopharma (ESLA) going to split?
There is no upcoming split for Estrella Immunopharma.
What sector and industry does Estrella Immunopharma (ESLA) operate in?
Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.